Sangamo Therapeutics Inc. (SGMO)

NASDAQ: SGMO · Real-Time Price · USD

0.74

-0.03 (-4.16%)

At close: May 01, 2025, 3:59 PM

0.75

1.00%

Pre-market: May 02, 2025, 09:11 AM EDT

Sangamo Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	57.8M	176.23M	111.3M	110.7M	118.19M	102.43M	84.45M	36.57M	19.39M
Cost of Revenue	9.36M	221.56M	12.11M	9.44M	180.65M	145.92M	114.87M	65.73M	65.62M
Gross Profit	48.44M	-45.33M	99.19M	101.26M	-62.45M	-43.49M	-30.41M	-29.16M	-46.23M
Operating Income	-103.97M	-274M	-201.28M	-183.34M	-129.55M	-105.18M	-77.15M	-56.36M	-72.56M
Interest Income	5.86M	11.1M	9.43M	5.35M	8.78M	9.76M	8.26M	n/a	n/a
Pretax Income	-98.11M	-262.9M	-191.85M	-177.99M	-120.78M	-95.42M	-68.89M	-54.57M	-71.67M
Net Income	-97.94M	-257.83M	-192.28M	-178.3M	-121.12M	-75.82M	-68.33M	-54.57M	-71.66M
Selling & General & Admin	44.73M	61.17M	62.68M	63.22M	67.1M	61.69M	46.74M	27.2M	26.33M
Research & Development	111.52M	234.06M	249.9M	230.82M	180.65M	145.92M	114.87M	65.73M	65.62M
Other Expenses	5.52M	155.01M	n/a	n/a	n/a	n/a	n/a	n/a	887K
Operating Expenses	161.77M	450.24M	312.58M	294.04M	247.74M	207.61M	161.6M	92.93M	91.95M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	161.77M	450.24M	312.58M	294.04M	247.74M	207.61M	161.6M	92.93M	91.95M
Income Tax Expense	-167K	-5.07M	429K	306K	345K	-19.6M	8.26M	-1.5M	-14K
Shares Outstanding (Basic)	201.7M	174.44M	154.34M	144.57M	134.45M	112.11M	96.94M	78.08M	70.55M
Shares Outstanding (Diluted)	201.7M	174.44M	154.34M	144.57M	134.45M	112.11M	96.94M	78.08M	70.55M
EPS (Basic)	-0.49	-1.48	-1.25	-1.23	-0.9	-0.68	-0.7	-0.7	-1.02
EPS (Diluted)	-0.49	-1.48	-1.25	-1.23	-0.9	-0.68	-0.7	-0.7	-1.02
EBITDA	-88.75M	-87.43M	-189.17M	-173.9M	-123.87M	-101.25M	-74.79M	-54.86M	-70.67M
EBIT	-98.45M	-118.99M	-201.28M	-183.34M	-129.55M	-105.18M	-77.15M	-56.36M	-71.67M
Depreciation & Amortization	9.36M	22.19M	12.11M	9.44M	5.68M	3.93M	2.36M	1.5M	997K